Philippe Nizard
Impact in
-
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Clusterin in disease pathology
- Colorectal Cancer Treatments and Studies
Papers in
-
- Innovative Microfluidic and Catalytic Techniques Innovation 5
- Nanoplatforms for cancer theranostics 3
- Co-authors
- Valérie Taly (11 shared papers)Pascale Le Goff (3 shared papers)Denis Michel (3 shared papers)Daniel Gillet (9 shared papers)Yves Le Dréan (2 shared papers)Alexandre Chenal (7 shared papers)Laure Debure (2 shared papers)Fabien Loison (2 shared papers)
In The Last Decade
Philippe Nizard
31 papers receiving 830 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 157
- Oncology 264
- Aging 13
- Immunology 150
- Biotechnology 56
Countries citing papers authored by Philippe Nizard
This map shows the geographic impact of Philippe Nizard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Nizard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Nizard more than expected).
Fields of papers citing papers by Philippe Nizard
This network shows the impact of papers produced by Philippe Nizard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Nizard. The network helps show where Philippe Nizard may publish in the future.
Co-authors
The 25 scholars most cited alongside Philippe Nizard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 120 | |
| 2 | 2014 | 118 | |
| 3 | 2006 | 107 | |
| 4 | 2002 | 64 | |
| 5 | 2018 | 57 | |
| 6 | 2017 | 48 | |
| 7 | 2015 | 38 | |
| 8 | 2002 | 31 | |
| 9 | 2004 | 31 | |
| 10 | 2002 | 31 | |
| 11 | 2018 | 26 | |
| 12 | 2001 | 21 | |
| 13 | 2017 | 19 | |
| 14 | 2018 | 17 | |
| 15 | 2022 | 16 | |
| 16 | 2003 | 14 | |
| 17 | 1998 | 13 | |
| 18 | 2015 | 11 | |
| 19 | 1998 | 11 | |
| 20 | 2015 | 10 |
About Philippe Nizard
Philippe Nizard is a scholar working on Biomedical Engineering, Molecular Biology, Oncology, Immunology and Biotechnology, having authored 31 papers that have together received 841 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (6 papers), Innovative Microfluidic and Catalytic Techniques Innovation (5 papers), Transgenic Plants and Applications (4 papers), CAR-T cell therapy research (4 papers), Gold and Silver Nanoparticles Synthesis and Applications (4 papers), Cancer Genomics and Diagnostics (4 papers), Nanoplatforms for cancer theranostics (3 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Cancer Research (157 citations), Oncology (264 citations), Aging (13 citations), Immunology (150 citations) and Biotechnology (56 citations). Philippe Nizard has collaborated with scholars based in France, Australia and Germany. Frequent co-authors include Valérie Taly, Pascale Le Goff, Denis Michel, Daniel Gillet, Yves Le Dréan, Alexandre Chenal, Laure Debure, Fabien Loison, Eleonora Zonta and Ouriel Caën. Their work appears in journals such as Protein Engineering Design and Selection, Scientific Reports, Molecular Therapy, Clinical Cancer Research and Traffic.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.